Since 2008 Policy Cures has reported on global investments into neglected disease research and development (R&D) through G-FINDER tools and reports. G-FINDER is a uniquely informative data source, providing policy-makers, funders, researchers and industry with objective, previously unavailable information on the state of investment, trends and patterns:
- in 34 neglected diseases,
- across 138 product areas for these diseases including drugs, vaccines, diagnostics, microbicides and vector control products and
- in platform technologies (e.g. delivery technologies, diagnostic platforms)
The data includes all types of product-related R&D, including basic research, discovery and preclinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.